Abstract:Abstract Identification of the driver genomic variants is important for precision therapy of human cancer. Interaction between RNA-binding proteins (RBPs) and RNA plays important roles in regulating cellular function. Decoding genome-wide protein-RNA regulatory networks as well as how cancer-related mutations impair RNA regulatory activities in cancer will help prioritizing candidate driver mutations. Here, we first explored the genetic alteration patterns of RBPs and found that candidate driver mutations are likely to occur on the surface of RBPs. This observations indicate that the driver mutations may perturb the RBP regulatory network in cancer. We then constructed protein-RNA interactome networks by integration of target binding screens and expression profiles. Regulatory network analysis highlights regulatory principles among interacting RBPs. In addition, somatic mutations selectively target functionally important genes (cancer genes, core fitness genes or conserved genes) in cancer. These regulatory patterns were further validated using independent data. A computational method (MERIT) and a web-based user friendly resource were further proposed to analyze the RBP-gene regulatory network perturbation induced by mutations across cancer types. Pan-cancer analysis also suggests that cancer cells selectively target "vulnerability" genes to perturb protein-RNA interactome that is involved in cancer hallmark-related functions. Based on the expression of perturbed RBP and target genes, we identified three subtypes of liver cancer with different survival rates. Specifically, we experimentally validated four pairs of RBP-gene interactions perturbed by mutations, which play critical roles in cell proliferation. Taken together, our results provide a valuable resource for characterizing somatic mutation-perturbed protein-RNA regulatory networks in cancer, yielding valuable insights into the genotype-phenotype relationships underlying human cancer, and potential biomarkers for precision medicine. Note: This abstract was not presented at the meeting. Citation Format: Yongsheng Li, Daniel J. McGrail, Juan Xu, Junyi Li, Song Yi, Nidhi Sahni. RNA interactome topology perturbation analysis reveals candidate driver mutations in cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 3390.

Alternative Splicing Perturbation Landscape Identifies RNA Binding Proteins As Potential Therapeutic Targets in Cancer.

Alternative splicing and related RNA binding proteins in human health and disease

Genome-wide identification and analysis of epithelial-mesenchymal transition-related RNA-binding proteins and alternative splicing in a human breast cancer cell line

Comprehensive Genomic Characterization of RNA-Binding Proteins Across Human Cancers.

OncoSplicing 3.0: an Updated Database for Identifying RBPs Regulating Alternative Splicing Events in Cancers.

RNA-Binding Proteins in Breast Cancer: Biological Implications and Therapeutic Opportunities

The interplay between non-coding RNAs and alternative splicing: from regulatory mechanism to therapeutic implications in cancer

Single-cell RNA binding protein regulatory network analyses reveal oncogenic HNRNPK-MYC signalling pathway in cancer

Systematic Profiling of Alternative Splicing Signature Reveals Prognostic Predictor for Prostate Cancer

Abstract 3390: RNA Interactome Topology Perturbation Analysis Reveals Candidate Driver Mutations in Cancer

Multidimensional Crosstalk Between RNA-binding Proteins and Noncoding RNAs in Cancer Biology.

Transcriptome-Wide Analysis Reveals The Landscape Of Aberrant Alternative Splicing Events In Liver Cancer

The underlying molecular mechanisms and prognostic factors of RNA binding protein in colorectal cancer: a study based on multiple online databases

RNA-binding proteins in tumor progression

Targeting RNA Binding Protein in Prostate Cancer

Dependency Of Prostate Cancer On Hnrnpl And Its Associated Rnas

Aberrant RNA Splicing Events Driven by Mutations of RNA-Binding Proteins as Indicators for Skin Cutaneous Melanoma Prognosis

Genome-wide identification of pan-cancer common and cancer-specific alternative splicing events in 9 types of cancer

Single-cell RNA-binding Protein Pattern-Mediated Molecular Subtypes Depict the Hallmarks of the Tumor Microenvironment in Bladder Urothelial Carcinoma

A pan-cancer analysis of alternative splicing of splicing factors in 6904 patients

RNA-binding proteins and cancer metastasis.